For consideration of Rs 511 croreMetropolis Healthcare announced that the Board of Directors has approved the acquisition of Dr. Ganesan s Hitech Diagnostic Centre (Hitech).
The acquisition will be a combination of cash and stock deal. The target entity is a debt free company. Cash consideration will be Rs. 511 crore and Metropolis will issue up to 4,95,000 equity shares of Face Value Rs.2/- each on preferential basis, subject to Shareholders approval, to
the Promoter Group of Hitech. The Cash consideration will be funded through internal accruals and Debt of up to Rs. 300 crore.
The acquisition will allow Metropolis to increase its B2C business in focus cities of Chennai and
Metropolis to acquire Hitech Diagnostic to strengthen position in South India
By IANS |
Published on
Mon, Jan 18 2021 14:42 IST |
0 Views
Doctors.. Image Source: IANS News
New Delhi, Jan 18 : Metropolis Healthcare, a leading diagnostic service provider announced that the Board of Directors has approved the acquisition of Dr. Ganesan s Hitech Diagnostic Centre Pvt. Ltd. (Hitech).
Metropolis will acquire 100 per cent equity of Dr. Ganesan s Hitech Diagnostic Centre Pvt. Ltd. in a combination of cash and stock deal. The entity is a debt free company.
Cash consideration will be Rs 511 crore and Metropolis will issue up to 4,95,000 equity shares of Face Value Rs 2/- each on preferential basis, subject to shareholders approval, to the Promoter Group of Hitech. The Cash consideration will be funded through internal accruals and Debt of up to Rs 300 crore.
Metropolis Healthcare announced that the board of directors has approved the acquisition of Dr. Ganesan s Hitech Diagnostic Centre (Hitech).
Established in 1986, Hitech Diagnostic Centre is a diagnostics laboratory chain in the South India market. Metropolis will acquire 100% equity of Dr. Ganesan s Hitech Diagnostic Centre in a combination of cash and stock deal. The entity is a debt free company. This acquisition is expected to be completed within 3 months.
Cash consideration will be Rs. 511 crore and Metropolis will issue up to 4,95,000 equity shares of Face Value Rs.2/- each on preferential basis, subject to Shareholders approval, to the Promoter Group of Hitech. The cash consideration will be funded through internal accruals and debt of up to Rs 300 crore.